Introduction Most of the current evidence regarding pneumococcal upper respiratory
colonization in adults suggests that despite high disease burden, carriage prevalence is low …

Streptococcus pneumoniae (the pneumococcus) is a nasopharyngeal commensal and
respiratory pathogen. Most isolates express a capsule, the species-wide diversity of which …

Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for
assessing the impact of 10-and 13-valent pneumococcal conjugate vaccines (PCV10/13) …

Streptococcus pneumoniae is an important cause of infection and commonly colonizes the
nasopharynx of young children, along with other potentially pathogenic bacteria. The …

Streptococcus pneumoniae (the pneumococcus) is a human pathogen responsible for a
spectrum of diseases such as pneumonia, sepsis, and meningitis. The capsule is the major …

Background The population impact of pneumococcal conjugate vaccines (PCVs) depends
on direct and indirect protection. Following Malawi's introduction of the 13-valent PCV …

Carriage of Streptococcus pneumoniae in adults is rarely detected by the gold standard
culture method. With molecular tests of high sensitivity now available, we analysed upper …

Reported rates of invasive pneumococcal disease were markedly lower than normal during
the 2020/2021 winter in the Northern Hemisphere, the first year after the start of the COVID …

Objective To evaluate the carriage prevalence, serotype distribution, and antibiotic
resistance for pneumococcal carriage isolates collected 4–8 years after introduction of …

Background The indirect effects of pneumococcal conjugate vaccines (PCVs) are mediated
through reductions in carriage of vaccine serotypes. Data on PCVs in Asia and the Pacific …